The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Multi-Organ Microfluidic Chip Market Research Report 2024

Global Multi-Organ Microfluidic Chip Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1764296

No of Pages : 87

Ask Your Query

Synopsis
Global Multi-Organ Microfluidic Chip market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Multi-Organ Microfluidic Chip market research.

Key companies engaged in the Multi-Organ Microfluidic Chip industry include CN Bio Innovations, Mimetas, Draper Laboratory, Kirkstall, Netri and Beijing Daxiang Biotech, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Multi-Organ Microfluidic Chip were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Multi-Organ Microfluidic Chip market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multi-Organ Microfluidic Chip market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • CN Bio Innovations
  • Mimetas
  • Draper Laboratory
  • Kirkstall
  • Netri
  • Beijing Daxiang Biotech

Segment by Type

  • Gut/Liver-on-a-chip
  • Lung/Liver-on-a-chip
  • Nerve/Muscle-on-a-chip
  • Heart/Liver-on-a-chip
  • Others

Segment by Application

  • Pharmaceutical
  • Research Institute
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Multi-Organ Microfluidic Chip report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multi-Organ Microfluidic Chip Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Gut/Liver-on-a-chip
1.2.3 Lung/Liver-on-a-chip
1.2.4 Nerve/Muscle-on-a-chip
1.2.5 Heart/Liver-on-a-chip
1.2.6 Others
1.3 Market by Application
1.3.1 Global Multi-Organ Microfluidic Chip Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical
1.3.3 Research Institute
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multi-Organ Microfluidic Chip Market Perspective (2018-2029)
2.2 Multi-Organ Microfluidic Chip Growth Trends by Region
2.2.1 Global Multi-Organ Microfluidic Chip Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Multi-Organ Microfluidic Chip Historic Market Size by Region (2018-2023)
2.2.3 Multi-Organ Microfluidic Chip Forecasted Market Size by Region (2024-2029)
2.3 Multi-Organ Microfluidic Chip Market Dynamics
2.3.1 Multi-Organ Microfluidic Chip Industry Trends
2.3.2 Multi-Organ Microfluidic Chip Market Drivers
2.3.3 Multi-Organ Microfluidic Chip Market Challenges
2.3.4 Multi-Organ Microfluidic Chip Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multi-Organ Microfluidic Chip Players by Revenue
3.1.1 Global Top Multi-Organ Microfluidic Chip Players by Revenue (2018-2023)
3.1.2 Global Multi-Organ Microfluidic Chip Revenue Market Share by Players (2018-2023)
3.2 Global Multi-Organ Microfluidic Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multi-Organ Microfluidic Chip Revenue
3.4 Global Multi-Organ Microfluidic Chip Market Concentration Ratio
3.4.1 Global Multi-Organ Microfluidic Chip Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multi-Organ Microfluidic Chip Revenue in 2022
3.5 Multi-Organ Microfluidic Chip Key Players Head office and Area Served
3.6 Key Players Multi-Organ Microfluidic Chip Product Solution and Service
3.7 Date of Enter into Multi-Organ Microfluidic Chip Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Multi-Organ Microfluidic Chip Breakdown Data by Type
4.1 Global Multi-Organ Microfluidic Chip Historic Market Size by Type (2018-2023)
4.2 Global Multi-Organ Microfluidic Chip Forecasted Market Size by Type (2024-2029)
5 Multi-Organ Microfluidic Chip Breakdown Data by Application
5.1 Global Multi-Organ Microfluidic Chip Historic Market Size by Application (2018-2023)
5.2 Global Multi-Organ Microfluidic Chip Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Multi-Organ Microfluidic Chip Market Size (2018-2029)
6.2 North America Multi-Organ Microfluidic Chip Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Multi-Organ Microfluidic Chip Market Size by Country (2018-2023)
6.4 North America Multi-Organ Microfluidic Chip Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multi-Organ Microfluidic Chip Market Size (2018-2029)
7.2 Europe Multi-Organ Microfluidic Chip Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Multi-Organ Microfluidic Chip Market Size by Country (2018-2023)
7.4 Europe Multi-Organ Microfluidic Chip Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multi-Organ Microfluidic Chip Market Size (2018-2029)
8.2 Asia-Pacific Multi-Organ Microfluidic Chip Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Multi-Organ Microfluidic Chip Market Size by Region (2018-2023)
8.4 Asia-Pacific Multi-Organ Microfluidic Chip Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multi-Organ Microfluidic Chip Market Size (2018-2029)
9.2 Latin America Multi-Organ Microfluidic Chip Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Multi-Organ Microfluidic Chip Market Size by Country (2018-2023)
9.4 Latin America Multi-Organ Microfluidic Chip Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multi-Organ Microfluidic Chip Market Size (2018-2029)
10.2 Middle East & Africa Multi-Organ Microfluidic Chip Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Multi-Organ Microfluidic Chip Market Size by Country (2018-2023)
10.4 Middle East & Africa Multi-Organ Microfluidic Chip Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CN Bio Innovations
11.1.1 CN Bio Innovations Company Detail
11.1.2 CN Bio Innovations Business Overview
11.1.3 CN Bio Innovations Multi-Organ Microfluidic Chip Introduction
11.1.4 CN Bio Innovations Revenue in Multi-Organ Microfluidic Chip Business (2018-2023)
11.1.5 CN Bio Innovations Recent Development
11.2 Mimetas
11.2.1 Mimetas Company Detail
11.2.2 Mimetas Business Overview
11.2.3 Mimetas Multi-Organ Microfluidic Chip Introduction
11.2.4 Mimetas Revenue in Multi-Organ Microfluidic Chip Business (2018-2023)
11.2.5 Mimetas Recent Development
11.3 Draper Laboratory
11.3.1 Draper Laboratory Company Detail
11.3.2 Draper Laboratory Business Overview
11.3.3 Draper Laboratory Multi-Organ Microfluidic Chip Introduction
11.3.4 Draper Laboratory Revenue in Multi-Organ Microfluidic Chip Business (2018-2023)
11.3.5 Draper Laboratory Recent Development
11.4 Kirkstall
11.4.1 Kirkstall Company Detail
11.4.2 Kirkstall Business Overview
11.4.3 Kirkstall Multi-Organ Microfluidic Chip Introduction
11.4.4 Kirkstall Revenue in Multi-Organ Microfluidic Chip Business (2018-2023)
11.4.5 Kirkstall Recent Development
11.5 Netri
11.5.1 Netri Company Detail
11.5.2 Netri Business Overview
11.5.3 Netri Multi-Organ Microfluidic Chip Introduction
11.5.4 Netri Revenue in Multi-Organ Microfluidic Chip Business (2018-2023)
11.5.5 Netri Recent Development
11.6 Beijing Daxiang Biotech
11.6.1 Beijing Daxiang Biotech Company Detail
11.6.2 Beijing Daxiang Biotech Business Overview
11.6.3 Beijing Daxiang Biotech Multi-Organ Microfluidic Chip Introduction
11.6.4 Beijing Daxiang Biotech Revenue in Multi-Organ Microfluidic Chip Business (2018-2023)
11.6.5 Beijing Daxiang Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock